Targeting a Granulocytic/Microbiome Axis Reverses Glioblastoma Progression via Intranasal Cannabidiol
Lei P. Wang, Bidhan Bhandari, Sahar Emami Naeini, James T Earwood, Brendan Marshall, Chandramohan G. Wakade, Jack Chung-Kai Yu, Ali S. Arbab, Évila Lopes Salles, Babak Baban
This study identifies a neuro-immune-microbiome axis in glioblastoma that can be targeted by intranasal cannabidiol to reverse tumor progression.
bioRxiv · Jul 13, 2026 · PreprintCancer Biology